Literature DB >> 28685519

Letter: Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015 (Endocrinol Metab 2017;32:106-14, Won Gu Kim et al.).

Young Ki Lee1, Dong Yeob Shin2.   

Abstract

Entities:  

Year:  2017        PMID: 28685519      PMCID: PMC5503877          DOI: 10.3803/EnM.2017.32.2.302

Source DB:  PubMed          Journal:  Endocrinol Metab (Seoul)        ISSN: 2093-596X


× No keyword cloud information.
Clinically, whether a patient has thyroid dysfunction is primarily screened for based on whether his or her thyroid stimulating hormone (TSH) level is within the normal range [1]. Therefore, the validity of the reference range of TSH is very important for ensuring informed clinical judgments. A previous report indicated that the reference range of TSH was higher in areas with high iodine intake [2]. Since iodine intake has been reported to be high in Koreans [3], it seems plausible that the serum TSH reference range would be somewhat high in the Korean population. However, no nationwide study had previously been conducted on the reference range of TSH in Korea. Recently, Kim et al. [4] evaluated the Korean reference range of serum TSH using Korea National Health and Nutrition Examination Survey (KNHANES) data from 2013 to 2015 and reported that the serum TSH reference range in Korea (0.62 to 6.86 mIU/L) was higher than the corresponding ranges in Western countries. This result was in line with that of a previous study by Kim et al. [5], in which the reference interval for TSH was reported to be 0.73 to 7.06 mIU/L. These results suggest that subclinical hypothyroidism in Korea may be overdiagnosed due to an inappropriately low TSH reference range. Nevertheless, applying the TSH reference values reported in this study directly to real clinical practice must be prudent with the following considerations. The National Academy of Clinical Biochemistry (NACB) suggested that the serum TSH reference range should be established in rigorously screened euthyroid volunteers who do not have goiter, anti-thyroid peroxidase antibody (TPOAb), or thyroglobulin antibody (TgAb) [1]. The KNHANES data provided information on TPOAb, but information on the results of ultrasonography or TgAb was not available. Therefore, it is possible that the high reference range could be attributed to the unintentional inclusion of persons with mild thyroid dysfunction induced by TPOAb-negative occult thyroiditis in this population. In this study, the mean TSH level was higher in females than in males. In contrast, in a previous United States study on this topic, the gender difference in the mean TSH level, which was significant in the disease-free population, disappeared in the reference population. These discrepancies may also indicate the possibility that mild thyroid dysfunction was not sufficiently excluded in this study [6]. The NACB also suggested that age-related normal reference limits should be used in children [1], but subjects aged 10 to 19 years were analyzed together with adults. In addition, the results of this study raise another question. If high iodine intake increases the estimated reference value of TSH, can we be sure that this is not because of the increased prevalence of iodine-associated hypothyroidism? Excess iodine intake may lead to hypothyroidism and autoimmune thyroiditis [7], and because we do not have a perfect way to screen for thyroid dysfunction, if the prevalence of thyroid dysfunction in the population is high, the proportion of misclassified subjects with occult thyroid dysfunction may also be high, even in the selected reference population. Therefore, although this study is valuable and important for understanding the patterns of thyroid hormone profiles in Korea, its results should be interpreted with caution. If we cannot suggest a complete explanation for the reason for the higher cut-off levels in the TSH reference interval of the Korean population, further studies with a more thorough exclusion of occult thyroid disease will be required to “re-define” the normal TSH level in Korea.
  6 in total

1.  Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt
Journal:  Thyroid       Date:  2003-01       Impact factor: 6.568

2.  Reference interval for thyrotropin in a ultrasonography screened Korean population.

Authors:  Mijin Kim; Tae Yong Kim; Soo Han Kim; Yunkyoung Lee; Su-yeon Park; Hyung-Don Kim; Hyemi Kwon; Yun Mi Choi; Eun Kyung Jang; Min Ji Jeon; Won Gu Kim; Young Kee Shong; Won Bae Kim
Journal:  Korean J Intern Med       Date:  2015-04-29       Impact factor: 2.884

3.  Effect of iodine intake on thyroid diseases in China.

Authors:  Weiping Teng; Zhongyan Shan; Xiaochun Teng; Haixia Guan; Yushu Li; Di Teng; Ying Jin; Xiaohui Yu; Chenling Fan; Wei Chong; Fan Yang; Hong Dai; Yang Yu; Jia Li; Yanyan Chen; Dong Zhao; Xiaoguang Shi; Fengnan Hu; Jinyuan Mao; Xiaolan Gu; Rong Yang; Yajie Tong; Weibo Wang; Tianshu Gao; Chenyang Li
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

4.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

5.  Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes.

Authors:  Haixia Guan; Zhongyan Shan; Xiaochun Teng; Yushu Li; Di Teng; Ying Jin; Xiaohui Yu; Chenling Fan; Wei Chong; Fan Yang; Hong Dai; Yang Yu; Jia Li; Yanyan Chen; Dong Zhao; Xiaoguang Shi; Fengnan Hu; Jinyuan Mao; Xiaolan Gu; Rong Yang; Wei Chen; Yajie Tong; Weibo Wang; Tianshu Gao; Chenyang Li; Weiping Teng
Journal:  Clin Endocrinol (Oxf)       Date:  2008-07-01       Impact factor: 3.478

6.  Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015.

Authors:  Won Gu Kim; Won Bae Kim; Gyeongji Woo; Hyejin Kim; Yumi Cho; Tae Yong Kim; Sun Wook Kim; Myung Hee Shin; Jin Woo Park; Hai Lin Park; Kyungwon Oh; Jae Hoon Chung
Journal:  Endocrinol Metab (Seoul)       Date:  2017-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.